Hepatitis C Community
AbbVie 96 percent SVR(12) IN Treatment-Experienced Patients with Genoty...
About This Community:

This forum is for questions about medical issues and research aspects of Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new Hepatitis Social/Living with Hepatitis forum

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

AbbVie 96 percent SVR(12) IN Treatment-Experienced Patients with Genotype 1A

NORTH CHICAGO, Ill., Dec. 10, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) released phase III results for the investigational three direct-acting-antiviral (3D) regimen plus ribavirin in patients with chronic, genotype 1 (GT1) hepatitis C virus (HCV) infection. In the 394-patient SAPPHIRE-II study, 96 percent of patients who previously failed pegylated interferon and ribavirin treatment, including approximately 49 percent of who were prior null responders, achieved sustained virologic response at 12 weeks (SVR12) with the regimen. The majority of patients were GT1a, considered a difficult-to-treat subtype, and the SVR12 rates of GT1a and GT1b were 96 percent and 97 percent, respectively.  MORE INFO HERE

http://hcvadvocate.blogspot.ca/2013/12/abbvie-demonstrates-96-percent-svr12-in.html
2 Comments Post a Comment
Blank
Avatar_m_tn
Have been following this trial and yes the results of the triple DAA combo is very encouraging.

Thx. for posting ...
Will
Blank
4113881_tn?1415853876
Interesting stuff, thanks for posting it.
Blank
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis C Community Resources
RSS Expert Activity
233488_tn?1310696703
Blank
Marathon Running Done Over Many Yea...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
233488_tn?1310696703
Blank
New Article on Multifocal IOL vs &q...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
748543_tn?1371753642
Blank
TMJ/TMJ The Connection Between Teet...
Jan 27 by Hamidreza Nassery , DMD, FICOI, FAGDBlank
Top Hepatitis Answerers
317787_tn?1428318779
Blank
Dee1956
DC
2059648_tn?1422055945
Blank
dontworry_behappy1
CA
Avatar_m_tn
Blank
can-do-man
IN
Avatar_f_tn
Blank
Livelife777
FL
446474_tn?1404424777
Blank
HectorSF
CA
Avatar_f_tn
Blank
AWorriedMom
NJ